Half-year report · Q2
6894.TEDINET S100URYW
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥972m | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥2.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥993m | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥56m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥69m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥53m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥387m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥88m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥39m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥112m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥25m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥327m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥76m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥25m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥76m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥4.4bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥5.2bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥4.5bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥907m | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.5bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.5bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.7bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.4bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.8bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.3bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.7bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.0bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥157m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥399m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥174m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥247m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥89m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥40m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥154m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥146m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥140m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥18.55 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥238.99 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.77 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 79.6% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.9% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.2% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥375m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥375m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥37m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥353m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥353m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥100m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥244m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥244m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥70m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥972m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥972m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥207m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥332m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥332m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥9m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥345m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥345m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥103m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥317m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥317m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥110m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥993m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥993m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥222m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 432
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)ときわ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)藤田 将司 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)佐藤 豪 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 993420000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 971509000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 2612074000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 88375000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 53340000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 386942000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 76304000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 25378000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 327009000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 93409000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 8238000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 352839000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 3415385000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 3532401000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 3674815000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 4479220000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 4439217000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 5182742000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 55.77 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 18.55 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 238.99 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.762 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.796 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.709 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 174038000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | -157238000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 398870000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | 40068000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -246972000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | 89344000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -139625000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -153665000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -146102000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 1995317000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 1696402000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 2267271000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1393459 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1393459 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 1393459 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 1393459 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 121000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.0887 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |